Translate
Lsl Pharma Group Inc
About
0.36CAD+0.01 +1.43%
Closed • Updated at 10:23 GMT+00:00Market Cap$28.92M
Volume25.9K
Beta0.34
RSI32.98
Gross Margin8.93%
Lsl Pharma Group Inc — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 30 2026
LSL PHARMA GROUP REPORTS ITS FOURTH QUARTER AND YEAR-END 2025 RESULTS
Apr 15 2026
LSL PHARMA GROUP INC. ANNOUNCES ITS PARTICIPATION IN THE "2026 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE"
Apr 9 2026
JUNO OTC, A WHOLLY-OWNED SUBSIDIARY OF LSL PHARMA GROUP, SIGNS BINDING TERM SHEET WITH INSTAPILL PRIVATE LIMITED TO SUPPLY PRIVATE LABEL LORATADINE 10 MG RDT IN CANADA
Feb 3 2026
LSL PHARMA GROUP GRANTS STOCK OPTIONS
Jan 28 2026
LSL PHARMA GROUP SUCCESSFULLY OBTAINED U.S. FDA CERTIFICATION FOR THE MANUFACTURING OF OPHTHALMIC OINTMENTS FOR COMMERCIALIZATION IN THE UNITED STATES
Recent Videos
LSL Pharma Group Fireside Chat @ Lytham Partners 2026 Investor Healthcare Summit
Jan 20, 2026
LSL Pharma Group (TSX-V: LSL): CDMO Focused on Natural and Ophthalmic Pharmaceutical Products
Feb 22, 2024
LSL Pharma Group (TSX-V: LSL) Presentation | Rivemont MicroCap Cocktail Event (January 2024)
Feb 08, 2024
Community Chat
Ask AI
Try asking